The cGAS-STING pathway: a therapeutic target in diabetes and its complications

Abstract

Diabetic wound healing (DWH) represents a major complication of diabetes where inflammation is a key impediment to proper healing. The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling pathway has emerged as a central mediator of inflammatory responses to cell stress and damage. However, the contribution of cGAS-STING activation to impaired healing in DWH remains understudied. In this review, we examine the evidence that cGAS-STING-driven inflammation is a critical factor underlying defective DWH. We summarize studies revealing upregulation of the cGAS-STING pathway in diabetic wounds and discuss how this exacerbates inflammation and senescence and disrupts cellular metabolism to block healing. Partial pharmaceutical inhibition of cGAS-STING has shown promise in damping inflammation and improving DWH in preclinical models. We highlight key knowledge gaps regarding cGAS-STING in DWH, including its relationships with endoplasmic reticulum stress and metal-ion signaling. Elucidating these mechanisms may unveil new therapeutic targets within the cGAS-STING pathway to improve healing outcomes in DWH. This review synthesizes current understanding of how cGAS-STING activation contributes to DWH pathology and proposes future research directions to exploit modulation of this pathway for therapeutic benefit.

Keywords

STING / Pyroptosis / Reprogramming / Diabetic liver disease / Diabetic wound / Endoplasmic reticulum stress / inflammation / Cyclic GMP-AMP synthase

References

[1] Hopfner KP, Hornung V. Molecular mechanisms and cellular functions of cGAS-STING signalling. Nat Rev Mol Cell Biol. 2020; 21: 501-21.

[2] Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol. 2015; 16: 343-53.

[3] Scutigliani EM, Kikkert M. Interaction of the innate immune system with positive-strand RNA virus replication organelles. Cytokine Growth Factor Rev. 2017; 37: 17-27.

[4] Burdette BE, Esparza AN, Zhu H, Wang S. Gasdermin D in pyroptosis. Acta Pharm Sin B. 2021; 11: 2768-82.

[5] Mogensen TH.Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009; 22: 240-73.

[6] Tang R, Xu J, Zhang B, Liu J, Liang C, Hua J, et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020; 13: 110.

[7] Gong T, Liu L, Jiang W, Zhou R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol. 2020; 20: 95-112.

[8] Li C, Liu W, Wang F, Hayashi T, Mizuno K, Hattori S, et al. DNA damage-triggered activation of cGAS-STING pathway induces apoptosis in human keratinocyte HaCaT cells. Mol Immunol. 2021; 131: 180-90.

[9] Pisetsky DS. The origin and properties of extracellular DNA: from PAMP to DAMP. Clin Immunol. 2012; 144: 32-40.

[10] West AP, Shadel GS. Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol. 2017; 17: 363-75.

[11] Dou Z, Ghosh K, Vizioli MG, Zhu J, Sen P, Wangensteen KJ, et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature. 2017; 550: 402-6.

[12] Ma Z, Damania B. The cGAS-STING Defense pathway and its counteraction by viruses. Cell Host Microbe. 2016; 19: 150-8.

[13] Austad SN, Ballinger S, Buford TW, Carter CS, Smith DL, Jr, Darley-Usmar V, et al. Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer’s disease. Acta Pharm Sin B. 2022; 12: 511-31.

[14] Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021; 21: 548-69.

[15] Bai J, Cervantes C, Liu J, He S, Zhou H, Zhang B, et al. DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway. Proc Natl Acad Sci U S A. 2017; 114: 12196-201.

[16] Eguchi K, Nagai R. Islet inflammation in type 2 diabetes and physiology. J Clin Invest. 2017; 127: 14-23.

[17] Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2020; 16: 442-9.

[18] Hotamisligil GS.Inflammation and metabolic disorders. Nature. 2006; 444: 860-7.

[19] Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022; 55: 31-55.

[20] Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006; 116: 1793-801.

[21] Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013; 93: 137-88.

[22] Bao T, Liu J, Leng J, Cai L. The cGAS-STING pathway: more than fighting against viruses and cancer. Cell Biosci. 2021; 11: 209.

[23] Mitrofanova A, Fontanella A, Tolerico M, Mallela S, Molina David J, Zuo Y, et al. Activation of stimulator of IFN genes (STING) causes proteinuria and contributes to glomerular diseases. J Am Soc Nephrol. 2022; 33: 2153-73.

[24] Myakala K, Jones BA, Wang XX, Levi M. Sacubitril/valsartan treatment has differential effects in modulating diabetic kidney disease in db/db mice and KKAy mice compared with valsartan treatment. Am J Physiol Renal Physiol. 2021; 320: F1133-f51.

[25] Ma XM, Geng K, Law BY, Wang P, Pu YL, Chen Q, et al. Lipotoxicity-induced mtDNA release promotes diabetic cardiomyopathy by activating the cGAS-STING pathway in obesity-related diabetes. Cell Biol Toxicol. 2022; 39: 277-99. https://doi.org/10.1007/s10565-021-09692-z.

[26] Audu CO, Melvin WJ, Joshi AD, Wolf SJ, Moon JY, Davis FM, et al. Macrophage-specific inhibition of the histone demethylase JMJD3 decreases STING and pathologic inflammation in diabetic wound repair. Cell Mol Immunol. 2022; 19: 1251-62.

[27] Geng K, Ma X, Jiang Z, Huang W, Gao C, Pu Y, et al. Innate immunity in diabetic wound healing: focus on the mastermind hidden in chronic inflammatory. Front Pharmacol. 2021; 12: 653940.

[28] Yan M, Li Y, Luo Q, Zeng W, Shao X, Li L, et al. Mitochondrial damage and activation of the cytosolic DNA sensor cGAS-STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice. Cell Death Discov. 2022; 8: 258.

[29] Hu H, Zhao R, He Q, Cui C, Song J, Guo X, et al. cGAS-STING mediates cytoplasmic mitochondrial-DNA-induced inflammatory signal transduction during accelerated senescence of pancreatic β-cells induced by metabolic stress. FASEB J. 2022; 36: e22266.

[30] Zhang Q, Liu S, Zhang CS, Wu Q, Yu X, Zhou R, et al. AMPK directly phosphorylates TBK1 to integrate glucose sensing into innate immunity. Mol Cell. 2022; 82: 4519-36.e7.

[31] Wong FS, Wen L. IFN-alpha can both protect against and promote the development of type 1 diabetes. Ann N Y Acad Sci. 2008; 1150: 187-9.

[32] Hamann L, Szwed M, Mossakowska M, Chudek J, Puzianowska-Kuznicka M. First evidence for STING SNP R293Q being protective regarding obesity-associated cardiovascular disease in age-advanced subjects-a cohort study. Immun Ageing. 2020; 17: 7.

[33] Lu QB, Ding Y, Liu Y, Wang ZC, Wu YJ, Niu KM, et al. Metrnl ameliorates diabetic cardiomyopathy via inactivation of cGAS/STING signaling dependent on LKB1/AMPK/ULK1-mediated autophagy. J Adv Res. 2022; 51: 161-79.

[34] Qiao J, Zhang Z, Ji S, Liu T, Zhang X, Huang Y, et al. A distinct role of STING in regulating glucose homeostasis through insulin sensitivity and insulin secretion. Proc Natl Acad Sci U S A. 2022; 119:e2101848119. https://doi.org/10.1073/pnas.2101848119.

[35] Akazawa S, Mackin L, Jhala G, Fynch S, Catterall T, Selck C, et al. Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice. Diabetologia. 2021; 64: 878-89.

[36] Kumar P, Liu C, Hsu JW, Chacko S, Minard C, Jahoor F, et al. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: results of a pilot clinical trial. Clin Transl Med. 2021; 11: e372.

[37] Ding X, Jian T, Wu Y, Zuo Y, Li J, Lv H, et al. Ellagic acid ameliorates oxidative stress and insulin resistance in high glucose-treated HepG2 cells via miR-223/keap1-Nrf2 pathway. Biomed Pharmacother. 2019; 110: 85-94.

[38] Xing YJ, Liu BH, Wan SJ, Cheng Y, Zhou SM, Sun Y, et al. A SGLT2 inhibitor Dapagliflozin alleviates diabetic cardiomyopathy by suppressing high glucose-induced oxidative stress in vivo and in vitro. Front Pharmacol. 2021; 12: 708177.

[39] Robertson RP, Harmon JS. Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell. Free Radic Biol Med. 2006; 41: 177-84.

[40] Sladitschek-Martens HL, Guarnieri A, Brumana G, Zanconato F, Battilana G, Xiccato RL, et al. YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS-STING. Nature. 2022; 607: 790-8.

[41] Aguado J, Chaggar HK, Gómez-Inclán C, Shaker MR, Leeson HC, Mackay-Sim A, et al. Inhibition of the cGAS-STING pathway ameliorates the premature senescence hallmarks of ataxia-telangiectasia brain organoids. Aging Cell. 2021; 20: e13468.

[42] Wan D, Jiang W, Hao J. Research advances in how the cGAS-STING pathway controls the cellular inflammatory response. Front Immunol. 2020; 11: 615.

[43] Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013; 339: 786-91.

[44] Li X, Shu C, Yi G, Chaton CT, Shelton CL, Diao J, et al. Cyclic GMP-AMP synthase is activated by double-stranded DNA-induced oligomerization. Immunity. 2013; 39: 1019-31.

[45] Chen Q, Sun L, Chen ZJ. Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing. Nat Immunol. 2016; 17: 1142-9.

[46] Li T, Huang T, Du M, Chen X, Du F, Ren J, et al. Phosphorylation and chromatin tethering prevent cGAS activation during mitosis. Science. 2021; 371: eabc5386.

[47] Motwani M, Pesiridis S, Fitzgerald KA. DNA sensing by the cGAS-STING pathway in health and disease. Nat Rev Genet. 2019; 20: 657-74.

[48] Takahashi A, Loo TM, Okada R, Kamachi F, Watanabe Y, Wakita M, et al. Downregulation of cytoplasmic DNases is implicated in cytoplasmic DNA accumulation and SASP in senescent cells. Nat Commun. 2018; 9: 1249.

[49] Mohr L, Toufektchan E, von Morgen P, Chu K, Kapoor A, Maciejowski J. ER-directed TREX1 limits cGAS activation at micronuclei. Mol Cell. 2021; 81: 724-38.e9.

[50] Hasan M, Gonugunta VK, Dobbs N, Ali A, Palchik G, Calvaruso MA, et al. Chronic innate immune activation of TBK1 suppresses mTORC1 activity and dysregulates cellular metabolism. Proc Natl Acad Sci U S A. 2017; 114: 746-51.

[51] Uhlorn BL, Gamez ER, Li S, Campos SK. Attenuation of cGAS/STING activity during mitosis. Life science alliance. 2020; 3: e201900636.

[52] Brandman O, Hegde RS. Ribosome-associated protein quality control. Nat Struct Mol Biol. 2016; 23: 7-15.

[53] Joazeiro CAP. Mechanisms and functions of ribosome-associated protein quality control. Nat Rev Mol Cell Biol. 2019; 20: 368-83.

[54] Inada T. Quality controls induced by aberrant translation. Nucleic Acids Res. 2020; 48: 1084-96.

[55] Wan L, Juszkiewicz S, Blears D, Bajpe PK, Han Z, Faull P, et al. Translation stress and collided ribosomes are co-activators of cGAS. Mol Cell. 2021; 81: 2808-22.e10.

[56] Ablasser A, Goldeck M, Cavlar T, Deimling T, Witte G, Röhl I, et al. cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING. Nature. 2013; 498: 380-4.

[57] Zhang X, Shi H, Wu J, Zhang X, Sun L, Chen C, et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell. 2013; 51: 226-35.

[58] Gao P, Ascano M, Zillinger T, Wang W, Dai P, Serganov AA, et al. Structure-function analysis of STING activation by c[G(2′,5′)pA(3′,5′)p] and targeting by antiviral DMXAA. Cell. 2013; 154: 748-62.

[59] Shang G, Zhang C, Chen ZJ, Bai XC, Zhang X. Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP-AMP. Nature. 2019; 567: 389-93.

[60] Tanaka Y, Chen ZJ. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci Signal. 2012; 5: ra20.

[61] Zhang C, Shang G, Gui X, Zhang X, Bai XC, Chen ZJ. Structural basis of STING binding with and phosphorylation by TBK1. Nature. 2019; 567: 394-8.

[62] Abe T, Barber GN. Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1. J Virol. 2014; 88: 5328-41.

[63] Balka KR, Louis C, Saunders TL, Smith AM, Calleja DJ, D’Silva DB, et al. TBK1 and IKKε act redundantly to mediate STING-induced NF-κB responses in myeloid cells. Cell Rep. 2020; 31: 107492.

[64] Cai H, Yan L, Liu N, Xu M, Cai H. IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway. Biomed Pharmacother. 2020; 123: 109790.

[65] Ergun SL, Fernandez D, Weiss TM, Li L. STING polymer structure reveals mechanisms for activation, Hyperactivation, and inhibition. Cell. 2019; 178: 290-301.e10.

[66] Yu X, Zhang L, Shen J, Zhai Y, Jiang Q, Yi M, et al. The STING phase-separator suppresses innate immune signalling. Nat Cell Biol. 2021; 23: 330-40.

[67] Wang PH, Fung SY, Gao WW, Deng JJ, Cheng Y, Chaudhary V, et al. A novel transcript isoform of STING that sequesters cGAMP and dominantly inhibits innate nucleic acid sensing. Nucleic Acids Res. 2018; 46: 4054-71.

[68] Dunphy G, Flannery SM, Almine JF, Connolly DJ, Paulus C, Jonsson KL, et al. Non-canonical activation of the DNA sensing adaptor STING by ATM and IFI16 mediates NF-kappaB Signaling after nuclear DNA damage. Mol Cell. 2018; 71: 745-60 e5.

[69] Fang R, Wang C, Jiang Q, Lv M, Gao P, Yu X, et al. NEMO-IKKbeta are essential for IRF3 and NF-kappaB activation in the cGAS-STING pathway. J Immunol. 2017; 199: 3222-33.

[70] de Oliveira Mann CC, Orzalli MH, King DS, Kagan JC, Lee ASY, Kranzusch PJ. Modular architecture of the STING C-terminal tail allows interferon and NF-κB Signaling adaptation. Cell Rep. 2019; 27: 1165-75.e5.

[71] Dunphy G, Flannery SM, Almine JF, Connolly DJ, Paulus C, Jønsson KL, et al. Non-canonical activation of the DNA sensing adaptor STING by ATM and IFI16 mediates NF-κB Signaling after nuclear DNA damage. Mol Cell. 2018; 71: 745-60.e5.

[72] Runde AP, Mack R, S.J. PB, Zhang J. The role of TBK1 in cancer pathogenesis and anticancer immunity. J Exp Clin Cancer Res. 2022; 41: 135.

[73] Yum S, Li M, Fang Y, Chen ZJ. TBK1 recruitment to STING activates both IRF3 and NF-κB that mediate immune defense against tumors and viral infections. Proc Natl Acad Sci U S A. 2021; 118.: e2100225118. https://doi.org/10.1073/pnas.2100225118.

[74] Zhao P, Wong KI, Sun X, Reilly SM, Uhm M, Liao Z, et al. TBK1 at the crossroads of inflammation and energy homeostasis in adipose tissue. Cell. 2018; 172: 731-43.e12.

[75] Seabright AP, Fine NHF, Barlow JP, Lord SO, Musa I, Gray A, et al. AMPK activation induces mitophagy and promotes mitochondrial fission while activating TBK1 in a PINK1-parkin independent manner. FASEB J. 2020; 34: 6284-301.

[76] Luo W, Ye L, Hu XT, Wang MH, Wang MX, Jin LM, et al. MD2 deficiency prevents high-fat diet-induced AMPK suppression and lipid accumulation through regulating TBK1 in non-alcoholic fatty liver disease. Clin Transl Med. 2022; 12: e777.

[77] Wang M, Xu R, Liu X, Zhang L, Qiu S, Lu Y, et al. A co-crystal berberine-ibuprofen improves obesity by inhibiting the protein kinases TBK1 and IKKε. Commun Biol. 2022; 5: 807.

[78] Taft J, Markson M, Legarda D, Patel R, Chan M, Malle L, et al. Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death. Cell. 2021; 184: 4447-63.e20.

[79] Fang R, Wang C, Jiang Q, Lv M, Gao P, Yu X, et al. NEMO-IKKβ are essential for IRF3 and NF-κB activation in the cGAS-STING pathway. J Immunol. 2017; 199: 3222-33.

[80] Konno H, Konno K, Barber GN. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell. 2013; 155: 688-98.

[81] Banerjee S, Biehl A, Gadina M, Hasni S, Schwartz DM. JAK-STAT Signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs. 2017; 77: 521-46.

[82] Hu X, Li J, Fu M, Zhao X, Wang W. The JAK/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. 2021; 6: 402.

[83] Galic S, Sachithanandan N, Kay TW, Steinberg GR. Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity. Biochem J. 2014; 461: 177-88.

[84] Solomon M, Flodström-Tullberg M, Sarvetnick N. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice. Transplantation. 2005; 79: 1104-9.

[85] Blumer T, Coto-Llerena M, Duong FHT, Heim MH. SOCS1 is an inducible negative regulator of interferon λ (IFN-λ)-induced gene expression in vivo. J Biol Chem. 2017; 292: 17928-38.

[86] Gurzov EN, Stanley WJ, Pappas EG, Thomas HE, Gough DJ. The JAK/STAT pathway in obesity and diabetes. FEBS J. 2016; 283: 3002-15.

[87] Dodington DW, Desai HR, Woo M. JAK/STAT-emerging players in metabolism. Trends Endocrinol Metab. 2018; 29: 55-65.

[88] Lu C, Kumar PA, Sun J, Aggarwal A, Fan Y, Sperling MA, et al. Targeted deletion of growth hormone (GH) receptor in macrophage reveals novel osteopontin-mediated effects of GH on glucose homeostasis and insulin sensitivity in diet-induced obesity. J Biol Chem. 2013; 288: 15725-35.

[89] Oh H, Park SH, Kang MK, Kim YH, Lee EJ, Kim DY, et al. Asaronic acid attenuates macrophage activation toward M1 phenotype through inhibition of NF-κB pathway and JAK-STAT Signaling in glucose-loaded murine macrophages. J Agric Food Chem. 2019; 67: 10069-78.

[90] Ge T, Jhala G, Fynch S, Akazawa S, Litwak S, Pappas EG, et al. The JAK1 selective inhibitor ABT 317 blocks Signaling through interferon-γ and common γ chain cytokine receptors to reverse autoimmune diabetes in NOD mice. Front Immunol. 2020; 11: 588543.

[91] Ho CH, Liao PW, Fan CK, Liu SP, Cheng PC. RNase 7 inhibits Uropathogenic Escherichia coli-induced inflammation in bladder cells under a high-glucose environment by regulating the JAK/STAT Signaling pathway. Int J Mol Sci. 2022; 23: 5156.

[92] Kandhaya-Pillai R, Yang X, Tchkonia T, Martin GM, Kirkland JL, Oshima J. TNF-α/IFN-γ synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK/STAT1. Aging Cell. 2022; 21: e13646.

[93] Yang L, Han X, Zhang C, Sun C, Huang S, Xiao W, et al. Hsa_circ_0060450 negatively regulates type I interferon-induced inflammation by serving as miR-199a-5p sponge in type 1 diabetes mellitus. Front Immunol. 2020; 11: 576903.

[94] Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol. 2010; 11: 997-1004.

[95] Anwar S, Ul Islam K, Azmi MI, Iqbal J. cGAS-STING-mediated sensing pathways in DNA and RNA virus infections: crosstalk with other sensing pathways. Arch Virol. 2021; 166: 3255-68.

[96] Jiang Z, Wei F, Zhang Y, Wang T, Gao W, Yu S, et al. IFI16 directly senses viral RNA and enhances RIG-I transcription and activation to restrict influenza virus infection. Nat Microbiol. 2021; 6: 932-45.

[97] Jønsson KL, Laustsen A, Krapp C, Skipper KA, Thavachelvam K, Hotter D, et al. IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP. Nat Commun. 2017; 8: 14391.

[98] Storek KM, Gertsvolf NA, Ohlson MB, Monack DM. cGAS and Ifi204 cooperate to produce type I IFNs in response to Francisella infection. J Immunol. 2015; 194: 3236-45.

[99] Almine JF, O’Hare CA, Dunphy G, Haga IR, Naik RJ, Atrih A, et al. IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes. Nat Commun. 2017; 8: 14392.

[100] Taffoni C, Steer A, Marines J, Chamma H, Vila IK, Laguette N. Nucleic acid immunity and DNA damage response: new friends and old foes. Front Immunol. 2021; 12: 660560.

[101] Gram AM, Sun C, Landman SL, Oosenbrug T, Koppejan HJ, Kwakkenbos MJ, et al. Human B cells fail to secrete type I interferons upon cytoplasmic DNA exposure. Mol Immunol. 2017; 91: 225-37.

[102] Choubey D.Cytosolic DNA sensor IFI16 proteins: potential molecular integrators of interactions among the aging hallmarks. Ageing Res Rev. 2022; 82: 101765.

[103] Li D, Wu R, Guo W, Xie L, Qiao Z, Chen S, et al. STING-mediated IFI16 degradation negatively Controls type I interferon production. Cell Rep. 2019; 29: 1249-60.e4.

[104] Her J, Bunting SF. How cells ensure correct repair of DNA double-strand breaks. J Biol Chem. 2018; 293: 10502-11.

[105] Chang HHY, Pannunzio NR, Adachi N, Lieber MR. Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat Rev Mol Cell Biol. 2017; 18: 495-506.

[106] Amalfi S, Molina GN, Bevacqua RJ, López MG, Taboga O, Alfonso V. Baculovirus transduction in mammalian cells is affected by the production of type I and III interferons, which is mediated mainly by the cGAS-STING pathway. J Virol. 2020; 94: e01555-20. https://doi.org/10.1128/jvi.01555-20.

[107] Liu H, Zhang H, Wu X, Ma D, Wu J, Wang L, et al. Nuclear cGAS suppresses DNA repair and promotes tumorigenesis. Nature. 2018; 563: 131-6.

[108] Burleigh K, Maltbaek JH, Cambier S, Green R, Gale M, Jr, James RC, et al. Human DNA-PK activates a STING-independent DNA sensing pathway. Sci Immunol. 2020; 5:eaba4219. doi.org/10.1126/sciimmunol.aba4219.

[109] Loi M, Raimondi A, Morone D, Molinari M. ESCRT-III-driven piecemeal micro-ER-phagy remodels the ER during recovery from ER stress. Nat Commun. 2019; 10: 5058.

[110] Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012; 13: 89-102.

[111] Senft D, Ronai ZA. UPR, autophagy, and mitochondria crosstalk underlies the ER stress response. Trends Biochem Sci. 2015; 40: 141-8.

[112] Rashid HO, Yadav RK, Kim HR, Chae HJ. ER stress: autophagy induction, inhibition and selection. Autophagy. 2015; 11: 1956-77.

[113] Nowotny K, Castro JP, Hugo M, Braune S, Weber D, Pignitter M, et al. Oxidants produced by methylglyoxal-modified collagen trigger ER stress and apoptosis in skin fibroblasts. Free Radic Biol Med. 2018; 120: 102-13.

[114] Ravi R, Ragavachetty Nagaraj N, Subramaniam RB. Effect of advanced glycation end product on paraoxonase 2 expression: its impact on endoplasmic reticulum stress and inflammation in HUVECs. Life Sci. 2020; 246: 117397.

[115] Desai K, Wu L. Methylglyoxal and advanced glycation end-products: new therapeutic horizons? Recent Pat Cardiovasc Drug Discov. 2007; 2: 89-99.

[116] Li H, O’Meara M, Zhang X, Zhang K, Seyoum B, Yi Z, et al. Ameliorating methylglyoxal-induced progenitor cell dysfunction for tissue repair in diabetes. Diabetes. 2019; 68: 1287-302.

[117] Bachar-Wikstrom E, Manchanda M, Bansal R, Karlsson M, Kelly-Pettersson P, Sköldenberg O, et al. Endoplasmic reticulum stress in human chronic wound healing: rescue by 4-phenylbutyrate. Int Wound J. 2021; 18: 49-61.

[118] Schurmann C, Goren I, Linke A, Pfeilschifter J, Frank S. Deregulated unfolded protein response in chronic wounds of diabetic Ob/Ob mice: a potential connection to inflammatory and angiogenic disorders in diabetes-impaired wound healing. Biochem Biophys Res Commun. 2014; 446: 195-200.

[119] Loughlin DT, Artlett CM. Precursor of advanced glycation end products mediates ER-stress-induced caspase-3 activation of human dermal fibroblasts through NAD(P)H oxidase 4. PLoS One. 2010; 5: e11093.

[120] Khan R, Kadamkode V, Kesharwani D, Purkayastha S, Banerjee G, Datta M. Circulatory miR-98-5p levels are deregulated during diabetes and it inhibits proliferation and promotes apoptosis by targeting PPP1R15B in keratinocytes. RNA Biol. 2020; 17: 188-201.

[121] Gkogkolou P, Sarna M, Sarna T, Paus R, Luger TA, Böhm M. Protection of glucotoxicity by a tripeptide derivative of α-melanocyte-stimulating hormone in human epidermal keratinocytes. Br J Dermatol. 2019; 180: 836-48.

[122] Figueiredo A, Leal EC, Carvalho E. Protein tyrosine phosphatase 1B inhibition as a potential therapeutic target for chronic wounds in diabetes. Pharmacol Res. 2020; 159: 104977.

[123] Yuan YF, Das SK, Li MQ. Vitamin D ameliorates impaired wound healing in Streptozotocin-induced diabetic mice by suppressing endoplasmic reticulum stress. J Diabetes Res. 2018; 2018: 1757925.

[124] Wottawa F, Bordoni D, Baran N, Rosenstiel P, Aden K. The role of cGAS/STING in intestinal immunity. Eur J Immunol. 2021; 51: 785-97.

[125] Wu J, Chen YJ, Dobbs N, Sakai T, Liou J, Miner JJ, et al. STING-mediated disruption of calcium homeostasis chronically activates ER stress and primes T cell death. J Exp Med. 2019; 216: 867-83.

[126] Aden K, Tran F, Ito G, Sheibani-Tezerji R, Lipinski S, Kuiper JW, et al. ATG16L1 orchestrates interleukin-22 signaling in the intestinal epithelium via cGAS-STING. J Exp Med. 2018; 215: 2868-86.

[127] Chen C, Zhang Y, Tao M, Zhao X, Feng Q, Fei X, et al. Atrial natriuretic peptide attenuates colitis via inhibition of the cGAS-STING pathway in colonic epithelial cells. Int J Biol Sci. 2022; 18: 1737-54.

[128] Zhang Y, Chen W, Wang Y. STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress. Biomed Pharmacother. 2020; 125: 110022.

[129] Moretti J, Roy S, Bozec D, Martinez J, Chapman JR, Ueberheide B, et al. STING senses microbial viability to orchestrate stress-mediated autophagy of the endoplasmic reticulum. Cell. 2017; 171: 809-23.e13.

[130] Petrasek J, Iracheta-Vellve A, Csak T, Satishchandran A, Kodys K, Kurt-Jones EA, et al. STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. Proc Natl Acad Sci U S A. 2013; 110: 16544-9.

[131] Ji Y, Luo Y, Wu Y, Sun Y, Zhao L, Xue Z, et al. SEL1L-HRD1 endoplasmic reticulum-associated degradation controls STING-mediated innate immunity by limiting the size of the activable STING pool. Nat Cell Biol. 2023; 25: 726-39.

[132] Wang X, Hu R, Song Z, Zhao H, Pan Z, Feng Y, et al. Sorafenib combined with STAT3 knockdown triggers ER stress-induced HCC apoptosis and cGAS-STING-mediated anti-tumor immunity. Cancer Lett. 2022; 547: 215880.

[133] Huang R, Shi Q, Zhang S, Lin H, Han C, Qian X, et al. Inhibition of the cGAS-STING pathway attenuates lung ischemia/reperfusion injury via regulating endoplasmic reticulum stress in alveolar epithelial type II cells of rats. J Inflamm Res. 2022; 15: 5103-19.

[134] Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N Engl J Med. 2009; 361: 1570-83.

[135] Fernandes-Alnemri T, Wu J, Yu JW, Datta P, Miller B, Jankowski W, et al. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 2007; 14: 1590-604.

[136] Zhu H, Zhao M, Chang C, Chan V, Lu Q, Wu H. The complex role of AIM2 in autoimmune diseases and cancers. Immun Inflamm Dis. 2021; 9: 649-65.

[137] Gaidt MM, Ebert TS, Chauhan D, Ramshorn K, Pinci F, Zuber S, et al. The DNA Inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3. Cell. 2017; 171: 1110-24.e18.

[138] Ning L, Wei W, Wenyang J, Rui X, Qing G. Cytosolic DNA-STING-NLRP3 axis is involved in murine acute lung injury induced by lipopolysaccharide. Clin Transl Med. 2020; 10: e228.

[139] Muñoz-Planillo R, Kuffa P, Martínez-Colón G, Smith BL, Rajendiran TM, Núñez G. K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity. 2013; 38: 1142-53.

[140] Banerjee I, Behl B, Mendonca M, Shrivastava G, Russo AJ, Menoret A, et al. Gasdermin D restrains type I interferon response to cytosolic DNA by disrupting ionic homeostasis. Immunity. 2018; 49: 413-26 e5.

[141] Mu X, Wu X, He W, Liu Y, Wu F, Nie X. Pyroptosis and inflammasomes in diabetic wound healing. Front Endocrinol (Lausanne). 2022; 13: 950798.

[142] Zhang W, Li G, Luo R, Lei J, Song Y, Wang B, et al. Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis. Exp Mol Med. 2022; 54: 129-42.

[143] Feltham R, Vince JE. Ion man: GSDMD punches pores to knock out cGAS. Immunity. 2018; 49: 379-81.

[144] Liu BC, Sarhan J, Panda A, Muendlein HI, Ilyukha V, Coers J, et al. Constitutive interferon maintains GBP expression required for release of bacterial components upstream of Pyroptosis and anti-DNA responses. Cell Rep. 2018; 24: 155-68.e5.

[145] Cheng Q, Pan J, Zhou ZL, Yin F, Xie HY, Chen PP, et al. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy. Acta Pharmacol Sin. 2021; 42: 954-63.

[146] Pastar I, Sawaya AP, Marjanovic J, Burgess JL, Strbo N, Rivas KE, et al. Intracellular Staphylococcus aureus triggers pyroptosis and contributes to inhibition of healing due to perforin-2 suppression. J Clin Invest. 2021; 131: e133727.

[147] Chen N, Deng J, Zhang Z, Feng X, Wang H, Chen J, et al. Oxidative stress-triggered pyroptosis mediates Candida albicans susceptibility in diabetic foot. Microb Pathog. 2022; 172: 105765.

[148] Yang H, Zhang Y, Du Z, Wu T, Yang C. Hair follicle mesenchymal stem cell exosomal lncRNA H19 inhibited NLRP3 pyroptosis to promote diabetic mouse skin wound healing. Aging (Albany NY). 2023; 15: 791-809.

[149] Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021; 18: 2114-27.

[150] Ao X, Yan H, Huang M, Xing W, Ao LQ, Wu XF, et al. Lavender essential oil accelerates lipopolysaccharide-induced chronic wound healing by inhibiting caspase-11-mediated macrophage pyroptosis. Kaohsiung J Med Sci. 2023; 39: 511-21.

[151] Ou ZL, Wang J, Shi R, Deng J, Liu Y, Luo GX. Influence of reactive oxygen species responsive self-assembled nanomicelle loaded with pyroptosis inhibitor on full-thickness skin defects in diabetic rats. Zhonghua Shao Shang Za Zhi. 2023; 39: 35-44.

[152] O’Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016; 16: 553-65.

[153] Icard P, Shulman S, Farhat D, Steyaert JM, Alifano M, Lincet H. How the Warburg effect supports aggressiveness and drug resistance of cancer cells? Drug Resist Updat. 2018; 38: 1-11.

[154] Chou WC, Rampanelli E, Li X, Ting JP. Impact of intracellular innate immune receptors on immunometabolism. Cell Mol Immunol. 2022; 19: 337-51.

[155] Vaupel P, Multhoff G. Revisiting the Warburg effect: historical dogma versus current understanding. J Physiol. 2021; 599: 1745-57.

[156] Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 2013; 496: 238-42.

[157] Olagnier D, Brandtoft AM, Gunderstofte C, Villadsen NL, Krapp C, Thielke AL, et al. Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming. Nat Commun. 2018; 9: 3506.

[158] Murphy MP, O’Neill LAJ. Krebs cycle reimagined: the emerging roles of succinate and Itaconate as signal transducers. Cell. 2018; 174: 780-4.

[159] Kelly B, O’Neill LA. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 2015; 25: 771-84.

[160] O’Neill LAJ, Artyomov MN. Itaconate: the poster child of metabolic reprogramming in macrophage function. Nat Rev Immunol. 2019; 19: 273-81.

[161] Russo S, Kwiatkowski M, Govorukhina N, Bischoff R, Melgert BN. Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: the importance of metabolites. Front Immunol. 2021; 12: 746151.

[162] Viola A, Munari F, Sánchez-Rodríguez R, Scolaro T, Castegna A. The metabolic signature of macrophage responses. Front Immunol. 2019; 10: 1462.

[163] Heinz A, Nonnenmacher Y, Henne A, Khalil MA, Bejkollari K, Dostert C, et al. Itaconate controls its own synthesis via feedback-inhibition of reverse TCA cycle activity at IDH2. Biochim Biophys Acta Mol basis Dis. 2022; 1868: 166530.

[164] Chen F, Elgaher WAM, Winterhoff M, Büssow K, Waqas FH, Graner E, et al. Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism. Nat Metab. 2022; 4: 534-46.

[165] Jha AK, Huang SC, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity. 2015; 42: 419-30.

[166] Peace CG, O’Neill LA. The role of itaconate in host defense and inflammation. J Clin Invest. 2022; 132: e148548. https://doi.org/10.1172/jci148548.

[167] Wang Q, Bergholz JS, Ding L, Lin Z, Kabraji SK, Hughes ME, et al. STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer. Nat Commun. 2022; 13: 3022.

[168] Gomes MTR, Guimarães ES, Marinho FV, Macedo I, Aguiar E, Barber GN, et al. STING regulates metabolic reprogramming in macrophages via HIF-1α during Brucella infection. PLoS Pathog. 2021; 17: e1009597.

[169] Olson GS, Murray TA, Jahn AN, Mai D, Diercks AH, Gold ES, et al. Type I interferon decreases macrophage energy metabolism during mycobacterial infection. Cell Rep. 2021; 35: 109195.

[170] Lam KC, Araya RE, Huang A, Chen Q, Di Modica M, Rodrigues RR, et al. Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment. Cell. 2021; 184: 5338-56.e21.

[171] Min BK, Park S, Kang HJ, Kim DW, Ham HJ, Ha CM, et al. Pyruvate dehydrogenase kinase is a metabolic checkpoint for polarization of macrophages to the M1 phenotype. Front Immunol. 2019; 10: 944.

[172] Dong L, Cheng R, Ma X, Liang W, Hong Y, Li H, et al. Regulation of monocyte activation by PPARα through interaction with the cGAS-STING pathway. Diabetes. 2023; 72: 958- 72.

[173] Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. The essence of senescence. Genes Dev. 2010; 24: 2463-79.

[174] Zierhut C, Yamaguchi N, Paredes M, Luo JD, Carroll T, Funabiki H. The cytoplasmic DNA sensor cGAS promotes mitotic cell death. Cell. 2019; 178: 302-15.e23.

[175] Lan YY, Heather JM, Eisenhaure T, Garris CS, Lieb D, Raychowdhury R, et al. Extranuclear DNA accumulates in aged cells and contributes to senescence and inflammation. Aging Cell. 2019; 18: e12901.

[176] Coluzzi E, Leone S, Sgura A. Oxidative stress induces telomere dysfunction and senescence by replication fork arrest. Cell. 2019; 8: 19.

[177] Rivera-Mulia JC, Schwerer H, Besnard E, Desprat R, Trevilla-Garcia C, Sima J, et al. Cellular senescence induces replication stress with almost no affect on DNA replication timing. Cell Cycle. 2018; 17: 1667-81.

[178] Dey G, Baum B. Nuclear envelope remodelling during mitosis. Curr Opin Cell Biol. 2021; 70: 67-74.

[179] Turgay Y, Eibauer M, Goldman AE, Shimi T, Khayat M, Ben-Harush K, et al. The molecular architecture of lamins in somatic cells. Nature. 2017; 543: 261-4.

[180] Shimi T, Kittisopikul M, Tran J, Goldman AE, Adam SA, Zheng Y, et al. Structural organization of nuclear lamins a, C, B1, and B2 revealed by superresolution microscopy. Mol Biol Cell. 2015; 26: 4075-86.

[181] Kittisopikul M, Shimi T, Tatli M, Tran JR, Zheng Y, Medalia O, et al. Computational analyses reveal spatial relationships between nuclear pore complexes and specific lamins. J Cell Biol. 2021; 220: e202007082. https://doi.org/10.1083/jcb.202007082.

[182] Evangelisti C, Rusciano I, Mongiorgi S, Ramazzotti G, Lattanzi G, Manzoli L, et al. The wide and growing range of Lamin B-related diseases: from laminopathies to cancer. Cell Mol Life Sci. 2022; 79: 126.

[183] Shimi T, Butin-Israeli V, Adam SA, Hamanaka RB, Goldman AE, Lucas CA, et al. The role of nuclear Lamin B1 in cell proliferation and senescence. Genes Dev. 2011; 25: 2579-93.

[184] Frediani E, Scavone F, Laurenzana A, Chillà A, Tortora K, Cimmino I, et al. Olive phenols preserve Lamin B1 expression reducing cGAS/STING/NFκB-mediated SASP in ionizing radiation-induced senescence. J Cell Mol Med. 2022; 26: 2337-50.

[185] Liang C, Ke Q, Liu Z, Ren J, Zhang W, Hu J, et al. BMAL1 moonlighting as a gatekeeper for LINE1 repression and cellular senescence in primates. Nucleic Acids Res. 2022; 50: 3323-47.

[186] Qi X, Zheng S, Ma M, Lian N, Wang H, Chen L, et al. Curcumol suppresses CCF-mediated hepatocyte senescence through blocking LC3B-Lamin B1 interaction in alcoholic fatty liver disease. Front Pharmacol. 2022; 13: 912825.

[187] Técher H, Pasero P. The replication stress response on a narrow path between genomic instability and inflammation. Front Cell Dev Biol. 2021; 9: 702584.

[188] Emam A, Wu X, Xu S, Wang L, Liu S, Wang B. Stalled replication fork protection limits cGAS-STING and P-body-dependent innate immune signalling. Nat Cell Biol. 2022; 24: 1154-64.

[189] Willaume S, Rass E, Fontanilla-Ramirez P, Moussa A, Wanschoor P, Bertrand P. A link between replicative stress, Lamin proteins, and inflammation. Genes (Basel). 2021; 12: 552.

[190] Donne R, Saroul-Ainama M, Cordier P, Hammoutene A, Kabore C, Stadler M, et al. Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD. Dev Cell. 2022; 57: 1728-41.e6.

[191] Luzwick JW, Dombi E, Boisvert RA, Roy S, Park S, Kunnimalaiyaan S, et al. MRE11-dependent instability in mitochondrial DNA fork protection activates a cGAS immune signaling pathway. Sci Adv. 2021; 7: eabf9441.

[192] Li X, Li X, Xie C, Cai S, Li M, Jin H, et al. cGAS guards against chromosome end-to-end fusions during mitosis and facilitates replicative senescence. Protein Cell. 2022; 13: 47-64.

[193] Nassour J, Radford R, Correia A, Fusté JM, Schoell B, Jauch A, et al. Autophagic cell death restricts chromosomal instability during replicative crisis. Nature. 2019; 565: 659-63.

[194] Lv N, Zhao Y, Liu X, Ye L, Liang Z, Kang Y, et al. Dysfunctional telomeres through mitostress-induced cGAS/STING activation to aggravate immune senescence and viral pneumonia. Aging Cell. 2022; 21: e13594.

[195] Rizwan H, Pal S, Sabnam S, Pal A. High glucose augments ROS generation regulates mitochondrial dysfunction and apoptosis via stress signalling cascades in keratinocytes. Life Sci. 2020; 241: 117148.

[196] Wang T, Li Y, Cornel EJ, Li C, Du J. Combined antioxidant-antibiotic treatment for effectively healing infected diabetic wounds based on polymer vesicles. ACS Nano. 2021; 15: 9027-38.

[197] Berlanga-Acosta JA, Guillen-Nieto GE, Rodriguez-Rodriguez N, Mendoza-Mari Y, Bringas-Vega ML, Berlanga-Saez JO, et al. Cellular senescence as the pathogenic hub of diabetes-related wound chronicity. Front Endocrinol (Lausanne). 2020; 11: 573032.

[198] Li B, Bian X, Hu W, Wang X, Li Q, Wang F, et al. Regenerative and protective effects of calcium silicate on senescent fibroblasts induced by high glucose. Wound Repair Regen. 2020; 28: 315-25.

[199] Senthil KK, Gokila VM, Mau JL, Lin CC, Chu FH, Wei CC, et al. A steroid like phytochemical Antcin M is an anti-aging reagent that eliminates hyperglycemia-accelerated premature senescence in dermal fibroblasts by direct activation of Nrf2 and SIRT-1. Oncotarget. 2016; 7: 62836-61.

[200] Gluck S, Guey B, Gulen MF, Wolter K, Kang TW, Schmacke NA, et al. Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence. Nat Cell Biol. 2017; 19: 1061-70.

[201] Madani AY, Majeed Y, Abdesselem HB, Agha MV, Vakayil M, Sukhun NKA, et al. Signal transducer and activator of transcription 3 (STAT3) suppresses STAT1/interferon Signaling pathway and inflammation in senescent Preadipocytes. Antioxidants (Basel). 2021; 10: 334.

[202] Lim DXE, Richards T, Kanapathy M, Sudhaharan T, Wright GD, Phillips ARJ, et al. Extracellular matrix and cellular senescence in venous leg ulcers. Sci Rep. 2021; 11: 20168.

[203] Liu Y, Liu Y, Deng J, Wu X, He W, Mu X, et al. Molecular mechanisms of marine-derived natural compounds as photoprotective strategies. Int Immunopharmacol. 2022; 111: 109174.

[204] Li W, Mu X, Wu X, He W, Liu Y, Liu Y, et al. Dendrobium nobile Lindl. Polysaccharides protect fibroblasts against UVA-induced photoaging via JNK/c-Jun/MMPs pathway. J Ethnopharmacol. 2022; 298: 115590.

[205] Kanwar YS, Sun L, Xie P, Liu FY, Chen S. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol. 2011; 6: 395-423.

[206] Dagar N, Das P, Bisht P, Taraphdar AK, Velayutham R, Arumugam S. Diabetic nephropathy: a twisted thread to unravel. Life Sci. 2021; 278: 119635.

[207] Rayego-Mateos S, Morgado-Pascual JL, Opazo-Ríos L, Guerrero-Hue M, García-Caballero C, Vázquez-Carballo C, et al. Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy. Int J Mol Sci. 2020; 21: 3798. https://doi.org/10.3390/ijms21113798.

[208] Wei PZ, Szeto CC. Mitochondrial dysfunction in diabetic kidney disease. Clin Chim Acta. 2019; 496: 108-16.

[209] Yang S, Han Y, Liu J, Song P, Xu X, Zhao L, et al. Mitochondria: a novel therapeutic target in diabetic nephropathy. Curr Med Chem. 2017; 24: 3185-202.

[210] Czajka A, Ajaz S, Gnudi L, Parsade CK, Jones P, Reid F, et al. Altered mitochondrial function, mitochondrial DNA and reduced metabolic flexibility in patients with diabetic nephropathy. EBioMedicine. 2015; 2: 499-512.

[211] Cao H, Wu J, Luo J, Chen X, Yang J, Fang L. Urinary mitochondrial DNA: a potential early biomarker of diabetic nephropathy. Diabetes Metab Res Rev. 2019; 35:e3131.

[212] Jin L, Yu B, Armando I, Han F. Mitochondrial DNA-mediated inflammation in acute kidney injury and chronic kidney disease. Oxidative Med Cell Longev. 2021; 2021: 9985603.

[213] Wei PZ, Kwan BC, Chow KM, Cheng PM, Luk CC, Li PK, et al. Urinary mitochondrial DNA level is an indicator of intrarenal mitochondrial depletion and renal scarring in diabetic nephropathy. Nephrol Dial Transplant. 2018; 33: 784-8.

[214] Ke G, Chen X, Liao R, Xu L, Zhang L, Zhang H, et al. Receptor activator of NF-κB mediates podocyte injury in diabetic nephropathy. Kidney Int. 2021; 100: 377-90.

[215] Yang H, Xie T, Li D, Du X, Wang T, Li C, et al. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway. Mol Metab. 2019; 23: 24-36.

[216] Chen D, Liu Y, Chen J, Lin H, Guo H, Wu Y, et al. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes. Eur J Pharmacol. 2021; 902: 174121.

[217] Gao C, Fei X, Wang M, Chen Q, Zhao N. Cardamomin protects from diabetes-induced kidney damage through modulating PI3K/AKT and JAK/STAT signaling pathways in rats. Int Immunopharmacol. 2022; 107: 108610.

[218] Ding T, Wang S, Zhang X, Zai W, Fan J, Chen W, et al. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome. Phytomedicine. 2018; 41: 45-53.

[219] Wada J, Makino H. Innate immunity in diabetes and diabetic nephropathy. Nat Rev Nephrol. 2016; 12: 13-26.

[220] Al Mamun A, Ara Mimi A, Wu Y, Zaeem M, Abdul Aziz M, Aktar Suchi S, et al. Pyroptosis in diabetic nephropathy. Clin Chim Acta. 2021; 523: 131-43.

[221] An X, Zhang Y, Cao Y, Chen J, Qin H, Yang L. Punicalagin protects diabetic nephropathy by inhibiting Pyroptosis based on TXNIP/NLRP3 pathway. Nutrients. 2020; 12: 1516.

[222] Reidy K, Kang HM, Hostetter T, Susztak K. Molecular mechanisms of diabetic kidney disease. J Clin Invest. 2014; 124: 2333-40.

[223] Barutta F, Bellini S, Gruden G. Mechanisms of podocyte injury and implications for diabetic nephropathy. Clin Sci (Lond). 2022; 136: 493-520.

[224] Zang N, Cui C, Guo X, Song J, Hu H, Yang M, et al. cGAS-STING activation contributes to podocyte injury in diabetic kidney disease. iScience. 2022; 25: 105145.

[225] Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol. 2022; 10: 284-96.

[226] Davis TME. Diabetes and metabolic dysfunction-associated fatty liver disease. Metabolism. 2021; 123: 154868.

[227] Kumar V, Xin X, Ma J, Tan C, Osna N, Mahato RI. Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis. Adv Drug Deliv Rev. 2021; 176: 113888.

[228] Fujii H, Kawada N, Japan Study Group Of Nafld J-N. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int J Mol Sci. 2020; 21: 3863. https://doi.org/10.3390/ijms21113863.

[229] Pang Y, Kartsonaki C, Turnbull I, Guo Y, Clarke R, Chen Y, et al. Diabetes, plasma glucose, and incidence of fatty liver, cirrhosis, and liver cancer: a prospective study of 0.5 million people. Hepatology. 2018; 68: 1308-18.

[230] Jick SS, Stender M, Myers MW. Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents. Diabetes Care. 1999; 22: 2067-71.

[231] Wang X, Rao H, Zhao J, Wee A, Li X, Fei R, et al. STING expression in monocyte-derived macrophages is associated with the progression of liver inflammation and fibrosis in patients with nonalcoholic fatty liver disease. Lab Investig. 2020; 100: 542-52.

[232] Luo X, Li H, Ma L, Zhou J, Guo X, Woo SL, et al. Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice. Gastroenterology. 2018; 155: 1971-84.e4.

[233] Luo Z, Ji Y, Zhang D, Gao H, Jin Z, Yang M, et al. Microbial DNA enrichment promotes liver steatosis and fibrosis in the course of non-alcoholic steatohepatitis. Acta Physiol (Oxf). 2022; 235: e13827.

[234] Bai J, Liu F. cGAS-STING signaling and function in metabolism and kidney diseases. J Mol Cell Biol. 2021; 13: 728-38.

[235] Qiao JT, Cui C, Qing L, Wang LS, He TY, Yan F, et al. Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease. Metabolism. 2018; 81: 13-24.

[236] Yu Y, Liu Y, An W, Song J, Zhang Y, Zhao X. STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis. J Clin Invest. 2019; 129: 546-55.

[237] Bai J, Liu F. The cGAS-cGAMP-STING pathway: a molecular link between immunity and metabolism. Diabetes. 2019; 68: 1099-108.

[238] Cho CS, Park HW, Ho A, Semple IA, Kim B, Jang I, et al. Lipotoxicity induces hepatic protein inclusions through TANK binding kinase 1-mediated p62/sequestosome 1 phosphorylation. Hepatology. 2018; 68: 1331-46.

[239] Dillmann WH. Diabetic cardiomyopathy. Circ Res. 2019; 124: 1160-2.

[240] Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014; 57: 660-71.

[241] Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity. Circ Res. 2018; 122: 624-38.

[242] Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016; 12: 144-53.

[243] Norton GR, Candy G, Woodiwiss AJ.Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats. Circulation. 1996; 93: 1905-12.

[244] Tschöpe C, Walther T, Escher F, Spillmann F, Du J, Altmann C, et al. Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy. FASEB J. 2005; 19: 2057-9.

[245] Elmadbouh I, Singla DK. BMP-7 attenuates inflammation-induced Pyroptosis and improves cardiac repair in diabetic cardiomyopathy. Cell. 2021; 10: 2640.

[246] Lafuse WP, Wozniak DJ, Rajaram MVS. Role of cardiac macrophages on cardiac inflammation. Fibrosis and Tissue Repair Cells. 2020; 10: 51.

[247] Abukhalil MH, Althunibat OY, Aladaileh SH, Al-Amarat W, Obeidat HM, Al-Khawalde AAA, et al. Galangin attenuates diabetic cardiomyopathy through modulating oxidative stress, inflammation and apoptosis in rats. Biomed Pharmacother. 2021; 138: 111410.

[248] Li L, Luo W, Qian Y, Zhu W, Qian J, Li J, et al. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses. Phytomedicine. 2019; 59: 152774.

[249] Bugger H, Abel ED. Rodent models of diabetic cardiomyopathy. Dis Model Mech. 2009; 2: 454-66.

[250] Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, et al. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes. 2007; 56: 2457-66.

[251] Fang WJ, Wang CJ, He Y, Zhou YL, Peng XD, Liu SK. Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation. Acta Pharmacol Sin. 2018; 39: 59-73.

[252] Smith SA, Travers RJ, Morrissey JH. How it all starts: initiation of the clotting cascade. Crit Rev Biochem Mol Biol. 2015; 50: 326-36.

[253] Wichaiyo S, Lax S, Montague SJ, Li Z, Grygielska B, Pike JA, et al. Platelet glycoprotein VI and C-type lectin-like receptor 2 deficiency accelerates wound healing by impairing vascular integrity in mice. Haematologica. 2019; 104: 1648-60.

[254] Powers JG, Higham C, Broussard K, Phillips TJ. Wound healing and treating wounds: chronic wound care and management. J Am Acad Dermatol. 2016; 74: 607-25 quiz 25-6.

[255] Okonkwo UA, DiPietro LA. Diabetes and wound angiogenesis. Int J Mol Sci. 2017; 18: 1419.

[256] Wei ZRJY. Discussion on surgical treatment mode of diabetic foot wounds. Chin J Burns Wounds. 2023; 39: 305-10.

[257] Nie X, Zhao J, Ling H, Deng Y, Li X, He Y. Exploring microRNAs in diabetic chronic cutaneous ulcers: regulatory mechanisms and therapeutic potential. Br J Pharmacol. 2020; 177: 4077-95.

[258] Murray PJ. Macrophage polarization. Annu Rev Physiol. 2017; 79: 541-66.

[259] Li M, Hou Q, Zhong L, Zhao Y, Fu X. Macrophage related chronic inflammation in non-healing wounds. Front Immunol. 2021; 12: 681710.

[260] Wu X, He W, Mu X, Liu Y, Deng J, Liu Y, et al. Macrophage polarization in diabetic wound healing. Burns Trauma. 2022; 10: tkac051.

[261] Louiselle AE, Niemiec SM, Zgheib C, Liechty KW. Macrophage polarization and diabetic wound healing. Transl Res. 2021; 236: 109-16.

[262] Li S, Yang P, Ding X, Zhang H, Ding Y, Tan Q. Puerarin improves diabetic wound healing via regulation of macrophage M2 polarization phenotype. Burns Trauma. 2022; 10: tkac046.

[263] Geng K, Ma X, Jiang Z, Huang W, Gu J, Wang P, et al. High glucose-induced STING activation inhibits diabetic wound healing through promoting M1 polarization of macrophages. Cell Death Discov. 2023; 9: 136.

[264] Bai J, Cervantes C, He S, He J, Plasko GR, Wen J, et al. Mitochondrial stress-activated cGAS-STING pathway inhibits thermogenic program and contributes to overnutrition-induced obesity in mice. Commun Biol. 2020; 3: 257.

[265] Yokota M, Häffner N, Kassier M, Brunner M, Shambat SM, Brennecke F, et al. Staphylococcus aureus impairs dermal fibroblast functions with deleterious effects on wound healing. FASEB J. 2021; 35: e21695.

[266] Yu T, Gao M, Yang P, Liu D, Wang D, Song F, et al. Insulin promotes macrophage phenotype transition through PI3K/Akt and PPAR-γ signaling during diabetic wound healing. J Cell Physiol. 2019; 234: 4217-31.

[267] Zhao J, Yang S, Shu B, Chen L, Yang R, Xu Y, et al. Transient high glucose causes persistent vascular dysfunction and delayed wound healing by the DNMT1-mediated Ang-1/NF-κB pathway. J Invest Dermatol. 2021; 141: 1573-84.

[268] Sharma RB, O’Donnell AC, Stamateris RE, Ha B, McCloskey KM, Reynolds PR, et al. Insulin demand regulates β cell number via the unfolded protein response. J Clin Invest. 2015; 125: 3831-46.

[269] Ueda K, Kawano J, Takeda K, Yujiri T, Tanabe K, Anno T, et al. Endoplasmic reticulum stress induces Wfs1 gene expression in pancreatic beta-cells via transcriptional activation. Eur J Endocrinol. 2005; 153: 167-76.

[270] Feng Z, Zang C, Zhang L, Yin S, Zhuang Q, Wang X. STING activation promotes inflammatory response and delays skin wound healing in diabetic mice. Biochem Biophys Res Commun. 2022; 611: 126-31.

[271] Xiaohong L, Zhenting Z, Yunjie Y, Wei C, Xiangjin X, Kun X, et al. Activation of the STING-IRF3 pathway involved in psoriasis with diabetes mellitus. J Cell Mol Med. 2022; 26: 2139-51.

[272] Yu Y, Xue X, Tang W, Su L, Zhang L, Zhang Y. Cytosolic DNA-mediated STING-dependent inflammation contributes to the progression of psoriasis. J Invest Dermatol. 2022; 142: 898-906.e4.

[273] Chiliveru S, Rahbek SH, Jensen SK, Jørgensen SE, Nissen SK, Christiansen SH, et al. Inflammatory cytokines break down intrinsic immunological tolerance of human primary keratinocytes to cytosolic DNA. J Immunol. 2014; 192: 2395-404.

[274] He L, Weber KJ, Diwan A, Schilling JD. Inhibition of mTOR reduces lipotoxic cell death in primary macrophages through an autophagy-independent mechanism. J Leukoc Biol. 2016; 100: 1113-24.

[275] He L, Weber KJ, Schilling JD. Glutamine modulates macrophage lipotoxicity. Nutrients. 2016; 8: 215.

[276] Mao Y, Luo W, Zhang L, Wu W, Yuan L, Xu H, et al. STING-IRF3 triggers endothelial inflammation in response to free fatty acid-induced mitochondrial damage in diet-induced obesity. Arterioscler Thromb Vasc Biol. 2017; 37: 920-9.

[277] Kumari M, Wang X, Lantier L, Lyubetskaya A, Eguchi J, Kang S, et al. IRF3 promotes adipose inflammation and insulin resistance and represses browning. J Clin Invest. 2016; 126: 2839-54.

[278] Guo X, Shu C, Li H, Pei Y, Woo SL, Zheng J, et al. Cyclic GMP-AMP ameliorates diet-induced metabolic dysregulation and regulates Proinflammatory responses distinctly from STING activation. Sci Rep. 2017; 7: 6355.

[279] Lima-Junior DS, Krishnamurthy SR, Bouladoux N, Collins N, Han SJ, Chen EY, et al. Endogenous retroviruses promote homeostatic and inflammatory responses to the microbiota. Cell. 2021; 184: 3794-811.e19.

[280] Kimball AS, Davis FM, denDekker A, Joshi AD, Schaller MA, Bermick J, et al. The histone Methyltransferase Setdb2 modulates macrophage phenotype and uric acid production in diabetic wound repair. Immunity. 2019; 51: 258-71.e5.

[281] Yang H, Song L, Sun B, Chu D, Yang L, Li M, et al. Modulation of macrophages by a paeoniflorin-loaded hyaluronic acid-based hydrogel promotes diabetic wound healing. Mater Today Bio. 2021; 12: 100139.

[282] Kimball A, Schaller M, Joshi A, Davis FM, denDekker A, Boniakowski A, et al. Ly6C(hi) blood monocyte/macrophage drive chronic inflammation and impair wound healing in diabetes mellitus. Arterioscler Thromb Vasc Biol. 2018; 38: 1102-14.

[283] Wang PCZ, Jiang LY, Zhou XQ, Jia CY, Xiao HA. Screening, functional analysis and clinical validation of differentially expressed genes in diabetic foot ulcers. Chin J Burns Wounds. 2022; 38: 944-51.

[284] Davis FM, Tsoi LC, Wasikowski R, denDekker A, Joshi A, Wilke C, et al. Epigenetic regulation of the PGE2 pathway modulates macrophage phenotype in normal and pathologic wound repair. JCI Insight. 2020; 5: e138443.

[285] Zhao J, Yang S, Shu B, Chen L, Yang R, Xu Y, et al. Transient high glucose causes persistent vascular dysfunction and delayed wound healing by the DNMT1-mediated Ang-1/NF-kappaB pathway. J Invest Dermatol. 2021; 141: 1573-84.

[286] Siqueira MF, Li J, Chehab L, Desta T, Chino T, Krothpali N, et al. Impaired wound healing in mouse models of diabetes is mediated by TNF-alpha dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia. 2010; 53: 378-88.

[287] Ramalho T, Filgueiras L, Silva-Jr IA, Pessoa AFM, Jancar S. Impaired wound healing in type 1 diabetes is dependent on 5-lipoxygenase products. Sci Rep. 2018; 8: 14164.

[288] Palomer X, Pizarro-Delgado J, Barroso E, Vázquez-Carrera M. Palmitic and oleic acid: the Yin and Yang of fatty acids in type 2 diabetes mellitus. Trends Endocrinol Metab. 2018; 29: 178-90.

[289] Yuan L, Mao Y, Luo W, Wu W, Xu H, Wang XL, et al. Palmitic acid dysregulates the hippo-YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS-STING-IRF3 signaling mechanism. J Biol Chem. 2017; 292: 15002-15.

[290] Riley JS, Tait SW. Mitochondrial DNA in inflammation and immunity. EMBO Rep. 2020; 21: e49799.

[291] Yan X, Yao C, Fang C, Han M, Gong C, Hu D, et al. Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer. Int J Biol Sci. 2022; 18: 585-98.

[292] Zhang Y, Li M, Li L, Qian G, Wang Y, Chen Z, et al. β-Arrestin 2 as an activator of cGAS-STING signaling and target of viral immune evasion. Nat Commun. 2020; 11: 6000.

[293] Duan D, Shang M, Han Y, Liu J, Liu J, Kong SH, et al. EZH2-CCF-cGAS Axis promotes breast cancer metastasis. Int J Mol Sci. 2022; 23: 1788.

[294] Liu B, Tang L, Zhang X, Ma J, Sehgal M, Cheng J, et al. A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists. Antivir Res. 2017; 147: 37-46.

[295] Chelvanambi M, Fecek RJ, Taylor JL, Storkus WJ. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. J Immunother Cancer. 2021; 9: 1788.

[296] Wu JJ, Zhao L, Han BB, Hu HG, Zhang BD, Li WH, et al. A novel STING agonist for cancer immunotherapy and a SARS-CoV-2 vaccine adjuvant. Chem Commun (Camb). 2021; 57: 504-7.

[297] Ma J, Liu Z, Zhou S, Chen M, Gao L, Zuo X, et al. Renal tubular in TCE-sensitization-induced immune kidney injury: role of mitochondrial DNA in activating the cGAS-STING signaling pathway. Int Immunopharmacol. 2022; 113: 109432.

[298] Domizio JD, Gulen MF, Saidoune F, Thacker VV, Yatim A, Sharma K, et al. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature. 2022; 603: 145-51.

[299] Tumurkhuu G, Chen S, Montano EN, Ercan Laguna D, De Los SG, Yu JM, et al. Oxidative DNA damage accelerates skin inflammation in Pristane-induced lupus model. Front Immunol. 2020; 11: 554725.

[300] Wei B, Xu L, Guo W, Wang Y, Wu J, Li X, et al. SHP2-mediated inhibition of DNA repair contributes to cGAS-STING activation and chemotherapeutic sensitivity in colon cancer. Cancer Res. 2021; 81: 3215-28.

[301] Haase S, Banerjee K, Mujeeb AA, Hartlage CS, Núñez FM, Núñez FJ, et al. H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models. J Clin Invest. 2022; 132: e154229. https://doi.org/10.1172/jci154229.

[302] Wang Y, Luo J, Alu A, Han X, Wei Y, Wei X. cGAS-STING pathway in cancer biotherapy. Mol Cancer. 2020; 19: 136.

[303] Kinkead HL, Hopkins A, Lutz E, Wu AA, Yarchoan M, Cruz K, et al. Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer. JCI Insight. 2018; 3:e122857. https://doi.org/10.1172/jci.insight.122857.

[304] Zang R, Xue L, Zhang M, Peng X, Li X, Du K, et al. Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist. Eur J Med Chem. 2023; 250: 115184.

[305] Ding R, Li H, Liu Y, Ou W, Zhang X, Chai H, et al. Activating cGAS-STING axis contributes to neuroinflammation in CVST mouse model and induces inflammasome activation and microglia pyroptosis. J Neuroinflammation. 2022; 19: 137.

[306] Thomsen MK, Skouboe MK, Boularan C, Vernejoul F, Lioux T, Leknes SL, et al. The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma. Oncogene. 2020; 39: 1652-64.

[307] Pei J, Zhang Y, Luo Q, Zheng W, Li W, Zeng X, et al. STAT3 inhibition enhances CDN-induced STING signaling and antitumor immunity. Cancer Lett. 2019; 450: 110-22.

[308] Vavřina Z, Perlíková P, Milisavljević N, Chevrier F, Smola M, Smith J, et al. Design, synthesis, and biochemical and biological evaluation of novel 7-Deazapurine cyclic dinucleotide analogues as STING receptor agonists. J Med Chem. 2022; 65: 14082-103.

[309] Xue A, Shang Y, Jiao P, Zhang S, Zhu C, He X, et al. Increased activation of cGAS-STING pathway enhances radiosensitivity of non-small cell lung cancer cells. Thorac Cancer. 2022; 13: 1361-8.

[310] Chin EN, Sulpizio A, Lairson LL. Targeting STING to promote antitumor immunity. Trends Cell Biol. 2023; 33: 189-203.

[311] He YQ, Zhou CC, Deng JL, Wang L, Chen WS. Tanreqing inhibits LPS-induced acute lung injury in vivo and in vitro through downregulating STING Signaling pathway. Front Pharmacol. 2021; 12: 746964.

[312] Wang L, Zhang Y, Ren Y, Yang X, Ben H, Zhao F, et al. Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and ameliorates organ fibrosis. Eur J Pharmacol. 2022; 932: 175241.

[313] Bennett ZT, Li S, Sumer BD, Gao J. Polyvalent design in the cGAS-STING pathway. Semin Immunol. 2021; 56: 101580.

[314] Lu Q, Chen R, Du S, Chen C, Pan Y, Luan X, et al. Activation of the cGAS-STING pathway combined with CRISPR-Cas9 gene editing triggering long-term immunotherapy. Biomaterials. 2022; 291: 121871.

[315] Wu YT, Fang Y, Wei Q, Shi H, Tan H, Deng Y, et al. Tumor-targeted delivery of a STING agonist improves cancer immunotherapy. Proc Natl Acad Sci U S A. 2022; 119: e2214278119.

[316] Gulla A, Morelli E, Samur MK, Botta C, Hideshima T, Bianchi G, et al. Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activation. Blood Cancer Discov. 2021; 2: 468-83.

[317] Vicencio JM, Evans R, Green R, An Z, Deng J, Treacy C, et al. Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans. Cell Death Dis. 2022; 13: 274.

[318] Ma X, Wu W, Liang W, Takahashi Y, Cai J, Ma JX. Modulation of cGAS-STING signaling by PPARα in a mouse model of ischemia-induced retinopathy. Proc Natl Acad Sci U S A. 2022; 119: e2208934119.

[319] Ullah TR, Balka KR, Ambrose RL, Pépin G, Wilce MCJ, Wilce JA, et al. Genistein targets STING-driven antiviral responses. MBio. 2022; 13: e0206422.

[320] Pan Y, You Y, Sun L, Sui Q, Liu L, Yuan H, et al. The STING antagonist H-151 ameliorates psoriasis via suppression of STING/NF-κB-mediated inflammation. Br J Pharmacol. 2021; 178: 4907-22.

[321] Tian X, Liu C, Wang Z. The induction of inflammation by the cGAS-STING pathway in human dental pulp cells: a laboratory investigation. Int Endod J. 2022; 55: 54-63.

[322] Wu S, Zhang Q, Zhang F, Meng F, Liu S, Zhou R, et al. HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity. Nat Cell Biol. 2019; 21: 1027-40.

[323] Fang R, Jiang Q, Guan Y, Gao P, Zhang R, Zhao Z, et al. Golgi apparatus-synthesized sulfated glycosaminoglycans mediate polymerization and activation of the cGAMP sensor STING. Immunity. 2021; 54: 962-75.e8.

[324] Ghosh M, Saha S, Bettke J, Nagar R, Parrales A, Iwakuma T, et al. Mutant p53 suppresses innate immune signaling to promote tumorigenesis. Cancer Cell. 2021; 39: 494-508.e5.

[325] Jere SW, Houreld NN, Abrahamse H. Photobiomodulation and the expression of genes related to the JAK/STAT signalling pathway in wounded and diabetic wounded cells. J Photochem Photobiol B. 2020; 204: 111791.

[326] Bako HY, Ibrahim MA, Isah MS, Ibrahim S. Inhibition of JAK-STAT and NF-κB signalling systems could be a novel therapeutic target against insulin resistance and type 2 diabetes. Life Sci. 2019; 239: 117045.

[327] Shumaker DK, Vann LR, Goldberg MW, Allen TD, Wilson KL. TPEN, a Zn2+/Fe2+ chelator with low affinity for Ca2+, inhibits Lamin assembly, destabilizes nuclear architecture and may independently protect nuclei from apoptosis in vitro. Cell Calcium. 1998; 23: 151-64.

[328] Wang C, Guan Y, Lv M, Zhang R, Guo Z, Wei X, et al. Manganese increases the sensitivity of the cGAS-STING pathway for double-stranded DNA and is required for the host Defense against DNA viruses. Immunity. 2018; 48: 675-87.e7.

[329] Rozenberg JM, Kamynina M, Sorokin M, Zolotovskaia M, Koroleva E, Kremenchutckaya K, et al. The role of the metabolism of zinc and manganese ions in human Cancerogenesis. Biomedicine. 2022; 10: 1072.

[330] Cen D, Ge Q, Xie C, Zheng Q, Guo J, Zhang Y, et al. ZnS@BSA nanoclusters potentiate efficacy of cancer immunotherapy. Adv Mater. 2021; 33: e2104037.

[331] Zhang L, Zhao J, Hu X, Wang C, Jia Y, Zhu C, et al. A Peritumorally injected Immunomodulating adjuvant elicits robust and safe Metalloimmunotherapy against solid Tumors. Adv Mater. 2022; 34: e2206915.

[332] Yi M, Niu M, Zhang J, Li S, Zhu S, Yan Y, et al. Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers. J Hematol Oncol. 2021; 14: 146.

[333] Zhang R, Wang C, Guan Y, Wei X, Sha M, Yi M, et al. Manganese salts function as potent adjuvants. Cell Mol Immunol. 2021; 18: 1222-34.

[334] Hou L, Tian C, Yan Y, Zhang L, Zhang H, Zhang Z. Manganese-based Nanoactivator optimizes cancer immunotherapy via enhancing innate immunity. ACS Nano. 2020; 14: 3927-40.

[335] Xian H, Watari K, Sanchez-Lopez E, Offenberger J, Onyuru J, Sampath H, et al. Oxidized DNA fragments exit mitochondria via mPTP-and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity. 2022; 55: 1370-85.e8.

[336] Srikanth S, Woo JS, Wu B, El-Sherbiny YM, Leung J, Chupradit K, et al. The Ca2+ sensor STIM1 regulates the type I interferon response by retaining the signaling adaptor STING at the endoplasmic reticulum. Nat Immunol. 2019; 20: 152-62.

[337] Malli R, Naghdi S, Romanin C, Graier WF. Cytosolic Ca2+ prevents the subplasmalemmal clustering of STIM1: an intrinsic mechanism to avoid Ca2+ overload. J Cell Sci. 2008; 121: 3133-9.

[338] Li H, Hu L, Wang L, Wang Y, Shao M, Chen Y, et al. Iron activates cGAS-STING Signaling and promotes hepatic inflammation. J Agric Food Chem. 2022; 70: 2211-20.

[339] Mizutani Y, Kanbe A, Ito H, Seishima M. Activation of STING signaling accelerates skin wound healing. J Dermatol Sci. 2020; 97: 21-9.

[340] Xiong Y, Leng Y, Tian H, Deng X, Li W, Li W, et al. Decreased MFN2 activates the cGAS-STING pathway in diabetic myocardial ischaemia-reperfusion by triggering the release of mitochondrial DNA. Cell Commun Signal. 2023; 21: 192.

[341] Pham PT, Fukuda D, Nishimoto S, Kim-Kaneyama JR, Lei XF, Takahashi Y, et al. STING, a cytosolic DNA sensor, plays a critical role in atherogenesis: a link between innate immunity and chronic inflammation caused by lifestyle-related diseases. Eur Heart J. 2021; 42: 4336-48.

[342] Lemos H, Mohamed E, Huang L, Chandler PR, Ou R, Pacholczyk R, et al. Stimulator of interferon genes agonists attenuate type I diabetes progression in NOD mice. Immunology. 2019; 158: 353-61.

[343] Pyclik M, Durslewicz J, Papinska JA, Deshmukh US, Bagavant H. STING agonist-induced skin inflammation is exacerbated with prior systemic innate immune activation. Int J Mol Sci. 2023; 24: 4128. https://doi.org/10.3390/ijms24044128.